In later studies, analysis of control and AD brain sections by immunohistochemistry with antibodies against NCAM found significantly fewer NCAM positive neurons in the frontal cortex of AD-affected individuals when compared to normal aging individuals [39]. This evidence concerns the gene NCAM1 and Alzheimer disease.